Special Issue
Modified lipoproteins as biomarkers of cardiovascular and metabolic diseases
Submission Deadline: 31 December 2018
Articles: 12
Special Issue Editor
Guest Editor
Ahmed Bakillah
PhD
DSc., State University of New York, Downstate Medical Center, Department of Medicine, 450 Clarkson Ave, Brooklyn, New York 11203, USA
Expertise: 33 publications, 1 grants, Editor of 8
Mohamed Zaiou
PhD., Université de Lorraine, Faculté de Pharmacie, 5 rue Albert Lebrun, 54000, Nancy, France
Expertise: 33 publications, 1 grants, Editor of 8
Manuscript Submission Information

Manuscripts should be submitted online at https://jour.ipublishment.com/bri by registering and logging into this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

Please visit the Instructions for Authors page before submitting a manuscript. Submitted papers should be well formatted and written in clear, concise English and should contain all essential data in order to make the presentation clear and the results of the study replicable. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see

here.

Keywords
Cardiovascular System, Cell Biology, Diagnostics, Genes and Genetics, Inflammatory Responses, Nutrition, Molecular Biology, Signaling, Technology, Therapeutics
Share This Special Issue
Published Papers (12 papers)
Open Access
Article

Diet-­induced differential effects on plasma lipids secretion by the inositol­-requiring transmembrane kinase/endoribonuclease 1α

Jahangir Iqbal, Ali Al Qarni, Ahmed Bakillah
Frontiers in Bioscience-Landmark Volume 26 Issue 5, pp.11-21
DOI: 10.52586/4920 Published: 30 April 2021
Open Access
Review

Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease

Hamid Moradi, Nosratola D. Vaziri
Frontiers in Bioscience-Landmark Volume 23 Issue 1, pp.146-161
DOI: 10.2741/4585 Published: 01 January 2018
Open Access
Review

The “forgotten” modified lipoprotein subspecies

Ahmed Bakillah, Mohamed Zaiou
Frontiers in Bioscience-Landmark Volume 23 Issue 3, pp.458-463
DOI: 10.2741/4599 Published: 01 January 2018
Open Access
Article

Association between nitrated lipoproteins and vascular function in type 2 diabetes

Ajibola Adedayo, Ayobami Eluwole, Fasika Tedla, Arye Kremer, Nicole Mastrogiovanni, Muhammad Khan, Carl Rosenberg, Paul Dreizen, John La Rosa, Louis Salciccioli, Mohamed Boutjdir, Mary Ann Banerji, Clinton Brown, Moro Salifu, Jason Lazar, Ahmed Bakillah
Frontiers in Bioscience-Landmark Volume 26 Issue 4, pp.644-663
DOI: 10.2741/4910 Published: 01 October 2020
Open Access
Review

Prenylcysteine oxidase 1, a pro-oxidant enzyme of low density lipoproteins

Luis V. Herrera-Marcos, Jose M. Lou-Bonafonte, Maria V. Martinez-Gracia, Carmen Arnal, Maria A. Navarro, Jesus Osada
Frontiers in Bioscience-Landmark Volume 23 Issue 6, pp.1020-1037
DOI: 10.2741/4631 Published: 01 January 2018
Open Access
Review

Lipoprotein(a) and cardiovascular disease: current state and future directions for an enigmatic lipoprotein

Anum Saeed, Salim S. Virani
Frontiers in Bioscience-Landmark Volume 23 Issue 6, pp.1099-1112
DOI: 10.2741/4635 Published: 01 January 2018
Open Access
Article

Modified low-density lipoproteins as biomarkers in diabetes and metabolic syndrome

Andrea Rivas-Urbina, Sonia Benitez, Antonio Perez, Jose Luis Sanchez-Quesada
Frontiers in Bioscience-Landmark Volume 23 Issue 7, pp.1220-1240
DOI: 10.2741/4640 Published: 01 January 2018
Open Access
Review

Enzymatically modified LDL, atherosclerosis and beyond: paving the way to acceptance

Michael Torzewski
Frontiers in Bioscience-Landmark Volume 23 Issue 7, pp.1257-1271
DOI: 10.2741/4642 Published: 01 January 2018
Open Access
Article

Modified lipoproteins as biomarkers of atherosclerosis

Alexander N. Orekhov, Igor A. Sobenin
Frontiers in Bioscience-Landmark Volume 23 Issue 8, pp.1422-1444
DOI: 10.2741/4653 Published: 01 March 2018
Open Access
Review

Effects of oxidized lipids and lipoproteins on cardiac function

Tahar Hajri
Frontiers in Bioscience-Landmark Volume 23 Issue 10, pp.1822-1847
DOI: 10.2741/4675 Published: 01 June 2018
Open Access
Review

Epigenetic regulation of genes involved in the reverse cholesterol transport through interaction with miRNAs

Mohamed Zaiou, Bertrand Henri Rihn, Ahmed Bakillah
Frontiers in Bioscience-Landmark Volume 23 Issue 11, pp.2090-2105
DOI: 10.2741/4692 Published: 01 June 2018
Open Access
Review

High-density lipoprotein carbamylation and dysfunction in vascular disease

Jeans M. Santana, Clinton D. Brown
Frontiers in Bioscience-Landmark Volume 23 Issue 12, pp.2227-2234
DOI: 10.2741/4701 Published: 01 June 2018